CORC

在结果中检索

CORC

浏览/检索结果: 共14条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes 期刊论文
2019, 卷号: 14, 页码: 1385-1400
作者:  Wang, Mengjiao;  Chen, Liqing;  Huang, Wei;  Jin, Mingji;  Wang, Qiming
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303 期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer 期刊论文
2018, 卷号: 122, 页码: 32-37
作者:  Si, Xiaoyan;  Zhang, Li;  Wang, Hanping;  Zhang, Xiaotong;  Wang, Mengzhao
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文
2018, 卷号: 15, 期号: 4, 页码: 443-451
作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice 期刊论文
2018, 卷号: 19, 期号: 12
作者:  Jin, Wenyu;  Huang, Wei;  Chen, Liqing;  Jin, Mingji;  Wang, Qiming
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
2017, 卷号: 18, 页码: S3-S3
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhao, Yizhuo;  Zhang, Li
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
2017, 卷号: 12, 期号: 1, 页码: S886-S887
作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma 期刊论文
2017, 卷号: 7, 期号: 2, 页码: 357-376
作者:  Fan, Bo;  Kang, Lin;  Chen, Liqing;  Sun, Ping;  Jin, Mingji
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis 期刊论文
2016, 卷号: 11, 页码: 4931-4945
作者:  Sun, Ping;  Huang, Wei;  Jin, Mingji;  Wang, Qiming;  Fan, Bo
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace